Secondary
Novavax, Inc.
Novavax is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Symbol
NVAX
Last Closing Price
$1.65
Anticipated Date
TBD
Underwriters
Citigroup, Piper Jaffray
To view the prospectus for Novavax, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277